Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (341-350 of 532) with videos related to

Pageof 54
Sort By:
FEBS Letters|June 5, 1989
Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptorB R de Costa, L Band, R B Rothman, et al.
European Journal of Pharmacology|October 6, 1987
Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomographyR B Rothman, S McLean, V Bykov, et al.
American Journal of Respiratory Cell and Molecular Biology|August 7, 2004
Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cellsNicola M Heller, Satoshi Matsukura, Steve N Georas, et al.
Synapse (New York, N.Y.)|December 1, 1993
Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domainsQ Ni, H Xu, J S Partilla, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2000
Delta opioid binding selectivity of 3-ether analogs of naltrindoleA Coop, J Pinto, L Wang, et al.
Circulation|January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medicationsR B Rothman, M H Baumann, J E Savage, et al.
Neurology|February 1, 1979
Lymphocyte adherence in multiple sclerosisP Dore-Duffy, R B Zurier, J Donaldson, et al.
Neuropeptides|December 1, 1985
Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: optimization of assay conditionsR B Rothman, V Bykov, J A Danks, et al.
Journal of Medicinal Chemistry|April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligandsB R de Costa, R B Rothman, V Bykov, et al.
Molecular Pharmacology|November 9, 2006
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalizationC E Groer, K Tidgewell, R A Moyer, et al.
Pageof 54

Showing results (341-350 of 532) with videos related to

Sort By:
Pageof 54
FEBS Letters|June 5, 1989
Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptorB R de Costa, L Band, R B Rothman, et al.
European Journal of Pharmacology|October 6, 1987
Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomographyR B Rothman, S McLean, V Bykov, et al.
American Journal of Respiratory Cell and Molecular Biology|August 7, 2004
Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cellsNicola M Heller, Satoshi Matsukura, Steve N Georas, et al.
Synapse (New York, N.Y.)|December 1, 1993
Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domainsQ Ni, H Xu, J S Partilla, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2000
Delta opioid binding selectivity of 3-ether analogs of naltrindoleA Coop, J Pinto, L Wang, et al.
Circulation|January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medicationsR B Rothman, M H Baumann, J E Savage, et al.
Neurology|February 1, 1979
Lymphocyte adherence in multiple sclerosisP Dore-Duffy, R B Zurier, J Donaldson, et al.
Neuropeptides|December 1, 1985
Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: optimization of assay conditionsR B Rothman, V Bykov, J A Danks, et al.
Journal of Medicinal Chemistry|April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligandsB R de Costa, R B Rothman, V Bykov, et al.
Molecular Pharmacology|November 9, 2006
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalizationC E Groer, K Tidgewell, R A Moyer, et al.
Pageof 54